Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Galustian

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
British Journal of Cancer|April 23, 2009
T-regulatory cell modulation: the future of cancer immunotherapy?S Nizar, J Copier, B Meyer, et al.
Biochemical and Biophysical Research Communications|December 3, 1999
Recombinant soluble human CD69 dimer produced in Escherichia coli: reevaluation of saccharide bindingR A Childs, C Galustian, A M Lawson, et al.
Retina (Philadelphia, Pa.)|January 1, 1995
Comparison of techniques for transscleral diode photocoagulation in the rabbitJ D Benner, J C Galustian, M Lim, et al.
British Journal of Cancer|July 30, 2009
Inhibition of metastatic potential in colorectal carcinoma in vivo and in vitro using immunomodulatory drugs (IMiDs)W M Liu, J Y Henry, B Meyer, et al.
The Prostate|October 5, 2011
Lenalidomide enhances the anti-prostate cancer activity of docetaxel in vitro and in vivoJ Y Henry, L Lu, M Adams, et al.
Biochemistry|April 29, 1997
Valency dependent patterns of binding of human L-selectin toward sialyl and sulfated oligosaccharides of Le(a) and Le(x) types: relevance to anti-adhesion therapeuticsC Galustian, R A Childs, C T Yuen, et al.
BMC Cancer|November 24, 2017
King's Health Partners' Prostate Cancer Biobank (KHP PCaBB)S R Saifuddin, W Devlies, A Santaolalla, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
British Journal of Cancer|April 23, 2009
T-regulatory cell modulation: the future of cancer immunotherapy?S Nizar, J Copier, B Meyer, et al.
Biochemical and Biophysical Research Communications|December 3, 1999
Recombinant soluble human CD69 dimer produced in Escherichia coli: reevaluation of saccharide bindingR A Childs, C Galustian, A M Lawson, et al.
Retina (Philadelphia, Pa.)|January 1, 1995
Comparison of techniques for transscleral diode photocoagulation in the rabbitJ D Benner, J C Galustian, M Lim, et al.
British Journal of Cancer|July 30, 2009
Inhibition of metastatic potential in colorectal carcinoma in vivo and in vitro using immunomodulatory drugs (IMiDs)W M Liu, J Y Henry, B Meyer, et al.
The Prostate|October 5, 2011
Lenalidomide enhances the anti-prostate cancer activity of docetaxel in vitro and in vivoJ Y Henry, L Lu, M Adams, et al.
Biochemistry|April 29, 1997
Valency dependent patterns of binding of human L-selectin toward sialyl and sulfated oligosaccharides of Le(a) and Le(x) types: relevance to anti-adhesion therapeuticsC Galustian, R A Childs, C T Yuen, et al.
BMC Cancer|November 24, 2017
King's Health Partners' Prostate Cancer Biobank (KHP PCaBB)S R Saifuddin, W Devlies, A Santaolalla, et al.
Pageof 2